Labcorp Holdings Inc.
358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 67,000
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Adam H. Schechter | President, CEO & Chairman | 4.66M | 無 | 1965 |
| Mr. Glenn A. Eisenberg | CFO & Executive VP | 1.87M | 無 | 1961 |
| Mr. Mark S. Schroeder | Executive VP, President of Diagnostics Laboratories & COO | 1.43M | 129.25k | 1961 |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1.3M | 無 | 1974 |
| Ms. Anita Z. Graham | Executive VP & Chief Human Resources Officer | 1.35M | 無 | 1971 |
| Mr. Peter J. Wilkinson | Senior VP & Chief Accounting Officer | 無 | 無 | 1971 |
| Mr. Lance V. Berberian | Executive VP and Chief Information & Technology Officer | 876.62k | 無 | 1963 |
| Christin O'Donnell | Vice President of Investor Relations | 無 | 無 | 無 |
| Ms. Sandra D. van der Vaart J.D. | Executive VP, Chief Legal Officer & Corporate Secretary | 無 | 無 | 1960 |
| Ms. Amy B. Summy | Executive VP & Chief Marketing Officer | 無 | 無 | 1966 |
描述
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
公司管治
截至 2024年9月1日 止，Labcorp Holdings Inc. 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中：6；董事會：8；股東權利：1；現金賠償：7。
